2 completed, 1 unknown. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Drug-resistant Tuberculosis: new trials by email Literature Review of Drug-resistant Tuberculosis trials Research Report on Drug-resistant Tuberculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis JDB0131, Delamanid, Ethylpyrazine rifampicide (II) - Drug-resistant Tuberculosis | Phase 2 | Unknown | Beijing Chest Hospital | 52 | 2023-10-31 | 2024-01-25 |
| A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Pretomanid, Bedaquiline, moxifloxacin - Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant | Phase 2 | Completed | Global Alliance for TB Drug Development | 26 | 2021-09-16 | 2025-01-17 |
| Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients Pretomanid, Bedaquiline, Moxifloxacin - Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant | Phase 2 / Phase 3 | Completed | Global Alliance for TB Drug Development | 455 | 2018-07-30 | 2026-08-27 |
Tuberculosis, Multidrug-Resistant (3) · Tuberculosis (2) · Tuberculosis, Pulmonary (2) · Extensively Drug-Resistant Tuberculosis (1)
Actinomycetales Infections (3) · Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Gram-Positive Bacterial Infections (3) · Infections (3) · Mycobacterium Infections (3) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Tuberculosis (1)
Moxifloxacin (2) · Pyrazinamide (2) · bedaquiline (2) · pretomanid (2) · Ethambutol (1) · Isoniazid (1) · OPC-67683 (1) · Rifampin (1)
Global Alliance for TB Drug Development (2) · Beijing Chest Hospital (1)
Georgia (2) · South Africa (2) · Brazil (1) · China (1) · Malaysia (1) · Philippines (1) · Russia (1) · Tanzania (1) · Uganda (1)
Antonio Lombardi, MD (1) · Morounfolu Olugbosi, MD MSc (1)